Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 20:12:662373.
doi: 10.3389/fneur.2021.662373. eCollection 2021.

Editorial: miRNAs and Neurological Diseases

Hsiuying Wang  1 , Y H Taguchi  2 , Xianshuang Liu  3
Affiliations
Editorial

Editorial: miRNAs and Neurological Diseases

Hsiuying Wang et al. Front Neurol. .
No abstract available

Keywords: biomarker; microRNA; neurological disease; target genes; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic miRNAs and Neurological Diseases

References

    1. Taguchi YH, Wang H. Exploring microRNA biomarkers for parkinson's disease from mRNA expression profiles. Cells. (2018) 7:245. 10.3390/cells7120245 - DOI - PMC - PubMed
    1. Taguchi YH, Wang H. Exploring microRNA biomarker for amyotrophic lateral sclerosis. Int J Mol Sci. (2018) 19:1318. 10.3390/ijms19051318 - DOI - PMC - PubMed
    1. Wang H. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis. Biocell. (2021) 45:547–61. 10.32604/biocell.2021.014343 - DOI
    1. Wen MM. Getting miRNA therapeutics into the target cells for neurodegenerative diseases: a mini-review. Front Mol Neurosci. (2016) 9:129. 10.3389/fnmol.2016.00129 - DOI - PMC - PubMed
    1. Titze-de-Almeida SS, Soto-Sánchez C, Fernandez E, Koprich JB, Brotchie JM, Titze-de-Almeida R. The promise and challenges of developing mirna-based therapeutics for Parkinson's disease. Cells. (2020) 9:841. 10.3390/cells9040841 - DOI - PMC - PubMed

Publication types

LinkOut - more resources